Seminars in Liver Disease (SLD)

Seminars in Liver Disease is a leading quarterly review journal in the field of hepatology, established in 1981, that provides in‑depth coverage of liver disease pathogenesis, diagnosis, management, and emerging therapies. It publishes high‑quality review articles authored by international experts, synthesizing current evidence and clinical practice across a broad spectrum of liver conditions such as viral hepatitis, cirrhosis, non‑alcoholic fatty liver disease, alcohol‑related liver injury, cholangiopathies, autoimmune liver disorders, and liver cancers. The journal also addresses critical topics in liver transplantation, vascular and coagulation disorders affecting the liver, drug‑induced liver injury, and genetic/metabolic liver diseases. Through comprehensive analyses of both basic and translational research, Seminars in Liver Disease supports clinicians, researchers, and trainees in hepatology by distilling complex scientific advances into clear, clinically relevant insights. Its rigorous peer‑review and expert editorial oversight ensure that content reflects the latest developments and best practices in patient care and research innovation. As a hybrid journal published by Thieme Medical Publishers, it is indexed in major databases including MEDLINE, EMBASE, and Scopus, enhancing its accessibility and impact within the global medical community.

Seminars in Liver Disease (SLD) is :-

• International, Peer-Reviewed, Open Access, Refereed, Emergency Medicine, General Medicine, Infectious Diseases, Internal Medicine, vascular and coagulation disorders, cytokines, hepatitis B & C, Nonalcoholic Steatosis Syndromes (NASH), pediatric liver diseases, hepatic stem cells , Online or Print , Quarterly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 0272-8087, E-ISSN: 1098-8971, Established: 1981, Impact Factor: 3.7
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE